Toxicogenomics and Toxicological Mechanisms of Engineered Nanomaterials

Impact of Engineered Nanomaterials in Genomics and Epigenomics | Vol. 309 | Issue 314 | 2023

DOI: https://doi.org/10.1002/9781119896258.ch13

Mechanistic and functional extrapolation of SET and MYND domain‑containing protein 2 to pancreatic cancer

World Journal of Gastroenterology | Vol. 28 | Issue 29 | 2022

DOI: https://doi.org/10.3748/wjg.v28.i29.3753

Aberrant DNA Methylation of Tumor Suppressor Genes and Oncogenes as Cancer Biomarkers

Genomic and Epigenomic Biomarkers of Toxicology and Disease: Clinical and Therapeutic Actions | Vol. 251 | Issue 273 | 2022

DOI: https://doi.org/10.1002/9781119807704.ch12

Emerging Non‑invasive Molecular Biomarkers for Early Cancer Detection

Genomic and Epigenomic Biomarkers of Toxicology and Disease: Clinical and Therapeutic Actions | Vol. 229 | Issue 250 | 2022

DOI: https://doi.org/10.1002/9781119807704.ch11

SMYD Protein Family as Promising Biomarkers for Cancer Diagnosis and Prognosis

Genomic and Epigenomic Biomarkers of Toxicology and Disease: Clinical and Therapeutic Actions | Vol. 273 | Issue 307 | 2022

DOI: https://doi.org/10.1002/9781119807704.ch13

ERK3 is transcriptionally upregulated by ∆Np63α and mediates the role of ∆Np63α in suppressing cell migration in non-melanoma skin cancers

BMC Cancer | Vol. 1 | 2021

DOI: https://doi.org/10.1186/s12885-021-07866-w